Cargando…
Nanomedicine Faces Barriers
Targeted nanoparticles have the potential to improve drug delivery efficiencies by more than two orders of magnitude, from the ~ 0.1% which is common today. Most pharmacologically agents on the market today are small drug molecules, which diffuse across the body’s blood-tissue barriers and distribut...
Autores principales: | Debbage, Paul, Thurner, Gudrun C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4034073/ http://dx.doi.org/10.3390/ph3113371 |
Ejemplares similares
-
Molecular imaging with nanoparticles: the dwarf actors revisited 10 years later
por: Thurner, Gudrun C., et al.
Publicado: (2018) -
Targeting Drug Delivery in the Elderly: Are Nanoparticles an Option for Treating Osteoporosis?
por: Thurner, Gudrun C., et al.
Publicado: (2021) -
Albumin-based nanoparticles: small, uniform and reproducible
por: Thalhammer-Thurner, Gudrun C., et al.
Publicado: (2023) -
Rac1 as a multifunctional therapeutic target to prevent and combat cancer metastasis
por: Arnold, Christoph R., et al.
Publicado: (2014) -
Overcoming Vascular Barriers to Improve the Theranostic Outcomes of Nanomedicines
por: Tang, Yufu, et al.
Publicado: (2022)